Validation of linear cerebral atrophy markers in multiple sclerosis

Journal of Clinical Neuroscience

Volumn 15, Issue 2, 2008, Pages 130-137

  Butzkueven, H ^a,b   Kolbe, S C ^b   Jolley, D J ^c   Brown, J Y ^a   Cook, M J ^d   van der Mei, I A F ^e   Groom, P S ^e   Carey, J ^a   Eckholdt, J ^a   Rubio, J P ^b   Taylor, B V ^f   Mitchell, P J ^a   Egan, G F ^b   Kilpatrick, T J ^a  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c MONASH UNIVERSITY   (Australia)

^d ST VINCENT S HOSPITAL   (Australia)

^e The Menzies Foundation   (Australia)

^f CHRISTCHURCH HOSPITAL   (New Zealand)

Author keywords

Atrophy; Biological markers; Disease progression; Magnetic resonance imaging; Multiple sclerosis; Patient monitoring

Indexed keywords

BIOLOGICAL MARKER;

ADULT; ARTICLE; BRAIN ATROPHY; BRAIN SIZE; BRAIN THIRD VENTRICLE; BRAIN VENTRICLE; CLINICAL ASSESSMENT; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; DISEASE MARKER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; MULTIPLE SCLEROSIS; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PARENCHYMA; PATIENT MONITORING; POPULATION RESEARCH; PRIORITY JOURNAL; VALIDATION PROCESS;

ADULT; ATROPHY; CEREBRAL CORTEX; FEMALE; HUMANS; IMAGING, THREE-DIMENSIONAL; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; PREDICTIVE VALUE OF TESTS; SEVERITY OF ILLNESS INDEX;

EID: 37449018037     PISSN: 09675868     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jocn.2007.02.089     Document Type: Article

References (37)

1. Confavreux C., Vukusic S., Moreau T., et al. Relapses and progression of disability in multiple sclerosis. N Engl J Med 343 (2000) 1430-1438
2. McFarland H.F., Frank J.A., Albert P.S., et al. Using gadolinium-enhanced magnetic resonance imaging of lesions to monitor disease activity in multiple sclerosis. Ann Neurol 32 (1992) 758-766
3. Filippi M., Horsfield M.A., Mirissey S.P., et al. Quantitative brain MRI lesion load predicts the course of clinically isolated syndromes suggestive of multiple sclerosis. Neurology 44 (1994) 635-641
4. Filippi M., Paty D.W., Kappos L., et al. Correlations between changes in disability and T2-weighted brain MRI activity in multiple scerosis: a follow-up study. Neurology 45 (1995) 255-260
5. Simon J.H., Jacobs L.D., and Campion M. Magnetic resonance studies of intramuscular interferon b-1a for relapsing multiple sclerosis. Ann Neurol 43 (1998) 79-87
6. Miller D.H., Barkhof F., Frank J.A., et al. Measurement of atrophy in multiple sclerosis: pathological basis, methodological aspects and clinical relevance. Brain 125 (2002) 1676-1695
7. Anderson V.M., Fox N.C., and Miller D.H. Magnetic resonance imaging measures of brain atrophy in multiple sclerosis. J Magn Reson Imaging 23 (2006) 605-618
8. Chard D.T., Griffin C.M., Rashid W., et al. Progressive grey matter atrophy in clinically early relapsing-remitting multiple sclerosis. Mult Scler 10 (2004) 387-391
9. De Stefano N., Matthews P.M., Fillipi M., et al. Evidence of early cortical atrophy in MS: relevance to white matter changes and disability. Neurology 60 (2003) 1157-1162
10. Amato M.P., Bartolozzi M.L., Zipoli V., et al. Neocortical volume decrease in relapsing-remitting MS patients with mild cognitive impairment. Neurology 63 (2004) 89-93
11. Bielekova B., Kadom N., Fisher E., et al. MRI as a marker for disease heterogeneity in multiple sclerosis. Neurology 65 (2005) 1071-1076
12. Freedman M.S., Patry D.G., Grand'Maison F., et al. Treatment optimization in multiple sclerosis. Can J Neurol Sci 31 (2004) 157-168
13. Simon J.H., Jacobs L.D., Campion M.K., et al. A longitudinal study of brain atrophy in relapsing multiple sclerosis. Neurology 53 (1999) 139-148
14. Berg D., Maurer M., Warmuth-Metz M., et al. The correlation between ventricular diameter measured by transcranial sonography and clinical disability and cognitive dysfunction in patients with multiple sclerosis. Arch Neurol 57 (2000) 1289-1292
15. Butzkueven H, Brown J, van der Me IAF, et al. Linear atrophy markers in MS. Presented at the 2000 6th Biennial Scientific Meeting, MS Australia; November 14, 2000; Melbourne.
16. Bermel R.A., Bakshi R., Tjoa C., et al. Bicaudate ratio as a magnetic resonance imaging marker of brain atrophy in multiple sclerosis. Arch Neurol 59 (2002) 275-280
17. Benedict R.H.B., Weinstock-Gutman B., Fishmann I., et al. Prediction of neuropsychological impairment in multiple sclerosis. Arch Neurol 61 (2004) 226-230
18. Caon C., Zvartau-Hind M., Ching W., et al. Intercaudate nucleus ratio as a linear measure of brain atrophy in multiple sclerosis. Neurology 60 (2003) 323-325
19. Doraiswamy P.M., Patterson L., Na C., et al. Bicaudate index on magnetic resonance imaging: effects of normal ageing. J Geriatr Psychiatry Neurol 7 (1994) 13-17
20. Starkstein S.E., Folstein S.E., Brandt J., et al. Brain atrophy in Huntington's disease: a CT-scan study. Neuroradiology 31 (1989) 156-159
21. Hestad K., McArthur J.H., Dal Pan G.J., et al. Regional brain atrophy in HIV-1 infection: association with specific neuropsychological test performance. Acta Neurol Scand 88 (1993) 112-118
22. Rubio J.P., Bahlo M., Butzkueven H., et al. Genetic dissection of the human leukocyte antigen region by use of haplotypes of Tasmanians with multiple sclerosis. Am J Hum Genet 70 (2002) 1125-1137
23. Poser C.M., Paty D.W., Scheinberg L., et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 13 (1983) 227-231
24. Paty D.W., Oger J.J., Kastrukoff L.F., et al. MRI in the diagnosis of MS: a prospective study with comparison of clinical evaluation, evoked potentials, oligoclonal banding, and CT. Neurology 38 (1988) 180-185
25. Smith S.M., Jenkinson M., Woolrich M.W., et al. Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage 23 (2004) 208-219
26. Smith S.M. Fast robust automated brain extraction. Hum Brain Mapp 17 (2002) 143-155
27. Jenkinson M., and Smith S.M. A global optimisation method for robust affine registration of brain images. Med Image Anal 5 (2001) 143-156
28. Zhang Y., Brady M., and Smith S. Segmentation of brain MR images through a hidden Markov random field model and the expectation maximization algorithm. IEEE Trans Med Imaging 20 (2001) 45-57
29. Gass A., Barker G.J., Kidd D., et al. Correlation of magnetization transfer ratio with clinical disability in multiple sclerosis. Ann Neurol 36 (1994) 62-67
30. Grimaud J., Barker G.J., Wang L., et al. Correlation of magnetic resonance imaging parameters with clinical disability in multiple sclerosis: a preliminary study. J Neurol 246 (1999) 961-967
31. Filippi M., Tortorella C., Rovaris M., et al. Changes in the normal appearing brain tissue and cognitive impairment in multiple sclerosis. J Neurol Neurosurg Psychiatry 68 (2000) 157-161
32. Filippi M., and Grossmann R.I. MRI techniques to monitor MS evolution. Neurology 58 (2002) 1147-1153
33. De Stefano N., Narayanan S., Francis G.S., et al. Evidence of axonal damage in the early stages of multiple sclerosis and its relevance to disability. Arch Neurol 58 (2001) 65-70
34. Truyen L., van Waehsberghe J.H.T.M., van Walverveen M.A.A., et al. Accumulation of hypointense lesions "black holes" on T1 spin echo MRI correlates with disease progression in multiple sclerosis. Neurology 47 (1996) 1469-1476
35. Simon J.H., Lull J., Jacobs L.D., et al. A longitudinal study of T1 hypointense lesions in relapsing MS. Neurology 55 (2000) 185-192
36. Bruck W., Bitsch A., Kolenda H., et al. Inflammatory central nervous system demyelination: correlation of magnetic resonance imaging findings with lesion pathology. Ann Neurol 42 (1997) 783-793
37. Bitsch A., Kuhlmann T., Stadelmann C., et al. A longitudinal MRI study of histopathologically defined hypointense multiple sclerosis lesions. Ann Neurol 49 (2001) 793-796